Guardant Health's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2022 was $225.4 Mil.
Guardant Health's quarterly Long-Term Capital Lease Obligation
increased
from Sep. 2021 ($216.8 Mil) to Dec. 2021 ($226.1 Mil) but then
declined
from Dec. 2021 ($226.1 Mil) to Mar. 2022 ($225.4 Mil).
Guardant Health's annual Long-Term Capital Lease Obligation
increased
from Dec. 2019 ($33.3 Mil) to Dec. 2020 ($41.6 Mil) and
increased
from Dec. 2020 ($41.6 Mil) to Dec. 2021 ($226.1 Mil).
Guardant Health Long-Term Capital Lease Obligation Historical Data
The historical data trend for Guardant Health's Long-Term Capital Lease Obligation can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Guardant Health Annual Data
Trend
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Long-Term Capital Lease Obligation
0.46
-
33.26
41.57
226.05
Guardant Health Quarterly Data
Dec16
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Long-Term Capital Lease Obligation
210.24
211.78
216.81
226.05
225.38
Guardant Health (NAS:GH) Long-Term Capital Lease Obligation Explanation
Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.
Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:
1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.
Guardant Health Long-Term Capital Lease Obligation Related Terms
Thank you for viewing the detailed overview of Guardant Health's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.
Guardant Health, based in Redwood City, California, provides cancer blood tests and analytics for clinical and research use, and the firm maintains research partnerships with large biopharmaceutical companies. The company offers Guardant 360, a blood-based (liquid biopsy) test for treatment selection in advanced stage cancer, and Guardant Omni, a broader gene panel for immuno-oncology research. The company's pipeline includes Guardant Reveal (formerly Lunar-1), for cancer recurrence detection in survivors, and Lunar-2, a liquid biopsy for early detection of cancer in higher-risk individuals, with an initial focus on colorectal cancer. Additionally, Guardant offers research development services. The United States accounts for 90% of total revenue, and other markets the remaining 10%.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
1.21(3.29%) Volume: 1,806,277 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NAS:GH has been successfully added to your 
